Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
The specific dermatoses of pregnancy represent a heterogeneous group of pruritic skin diseases that have been recently reclassified and include pemphigoid (herpes)gestationis, polymorphic eruption of pregnancy (syn. pruritic urticarial papules and plaques of pregnancy), intrahepatic cholestasis of pregnancy, and atopic eruption of pregnancy. They are associated with severe pruritus that should never be neglected in pregnancy but always lead to an exact work-up of the patient. Clinical characteristics, in particular timing of onset, morphology and localization of skin lesions are crucial for diagnosis which, in case of pemphigoid gestationis and intrahepatic cholestasis of pregnancy, will be confirmed by specific immunofluorescence and laboratory findings. While polymorphic and atopic eruptions of pregnancy are distressing only to the mother because of pruritus, pemphigoid gestationis may be associated with prematurity and small-for-date babies and intrahepatic cholestasis of pregnancy poses an increased risk for fetal distress, prematurity, and stillbirth. Corticosteroids and antihistamines control pemphigoid gestationis, polymorphic and atopic eruptions of pregnancy; intrahepatic cholestasis of pregnancy, in contrast, should be treated with ursodeoxycholic acid. This review will focus on the new classification of pregnancy dermatoses, discuss them in detail, and present a practical algorithm to facilitate the management of the pregnant patient with skin lesions. (Ann Dermatol 23(3) 265∼275, 2011)
Abstract
The specific dermatoses of pregnancy represent a heterogeneous group of pruritic skin diseases that have been recently reclassified and include pemphigoid (herpes)gestationis, polymorphic eruption of pregnancy (syn. pruritic urticarial papules and plaques of pregnancy), intrahepatic cholestasis of pregnancy, and atopic eruption of pregnancy. They are associated with severe pruritus that should never be neglected in pregnancy but always lead to an exact work-up of the patient. Clinical characteristics, in particular timing of onset, morphology and localization of skin lesions are crucial for diagnosis which, in case of pemphigoid gestationis and intrahepatic cholestasis of pregnancy, will be confirmed by specific immunofluorescence and laboratory findings. While polymorphic and atopic eruptions of pregnancy are distressing only to the mother because of pruritus, pemphigoid gestationis may be associated with prematurity and small-for-date babies and intrahepatic cholestasis of pregnancy poses an increased risk for fetal distress, prematurity, and stillbirth. Corticosteroids and antihistamines control pemphigoid gestationis, polymorphic and atopic eruptions of pregnancy; intrahepatic cholestasis of pregnancy, in contrast, should be treated with ursodeoxycholic acid. This review will focus on the new classification of pregnancy dermatoses, discuss them in detail, and present a practical algorithm to facilitate the management of the pregnant patient with skin lesions. (Ann Dermatol 23(3) 265∼275, 2011)
참고문헌 (43)
- Shornick JK, "Pregnancy dermatoses. In Dermatology", pp.425~432 (2003), London, Edinburgh, New York, Philadelphia, St. Louis, Sydney, Toronto: Mosby
- Ambros-Rudolph CM, "Disorders of pregnancy. In Braun-Falco’s dermatology. 3rd ed", pp.1160~1169 (2009), Heidelberg: Springer Medizin Verlag
- Ambros-Rudolph CM, "The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients", J Am Acad Dermatol, 54, pp.395~404 (2006)
- Milton JL, "The pathology and treatment of diseases of the skin", pp.205~ (1872), London: Robert Hardwicke
- Besnier E, "Prurigo of pregnancy. In La pratique dermatologique", pp.75~ (1904), Paris, France: Masson et Cie
- Costello MJ, "Eruptions of pregnancy", NY State J Med, 41, pp.849~855 (1941)
- Nurse DS, "Prurigo of pregnancy", Australas J Dermatol, 9, pp.258~267 (1968)
- Bourne G, "Toxaemic rash of pregnancy", Proc R Soc Med, 55, pp.462~464 (1962)
- Holmes RC, "A comparative study of toxic erythema of pregnancy and herpes gestationis", Br J Dermatol, 106, pp.499~510 (1982)
- Lawley TJ, "Pruritic urticarial papules and plaques of pregnancy", JAMA, 241, pp.1696~1699 (1979)
- Spangler AS, "Papular dermatitis of pregnancy. A new clinical entity", JAMA, 181, pp.577~581 (1962)
- Vaughan Jones SA, "A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles", Br J Dermatol, 141, pp.71~81 (1999)
- Holmes RC, "The specific dermatoses of pregnancy", J Am Acad Dermatol, 8, pp.405~412 (1983)
- Zoberman E, "Pruritic folliculitis of pregnancy", Arch Dermatol, 117, pp.20~22 (1981)
- Shornick JK, "Dermatoses of pregnancy", Semin Cutan Med Surg, 17, pp.172~181 (1998)
- Jenkins RE, "Pemphigoid (herpes) gestationis. In Obstetric and gynecologic dermatology. 3rd ed", pp.37~47 (2008), London: Elsevier Limited
- Zilikens D, "Pemphigoid gestationis: recent advances", JEADV, 17(3), pp.7~ (2003)
- Chi CC, "Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes", Br J Dermatol, 160, pp.1222~1228 (2009)
- Schaefer C, "Arzneiverordnung in Schwangerschaft und Stillzeit, 7" (2006), München: Urban & Fischer Verlag
- Briggs GG, "Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 8th ed" (2008), Philadelphia: Lippincot Williams & Wilkins
- Wöhrl S, "Pemphigoid gestationis: treatment with immunoapheresis", J Dtsch Dermatol Ges, 1, pp.126~130 (2006)
- Rudolph CM, "Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients", Br J Dermatol, 154, pp.54~60 (2006)
- Ambros-Rudolph CM, "Polymorphic eruption of pregnancy. In Obstetric and gynecologic dermatology. 3rd ed", pp.49~56 (2008), London: Elsevier Limit
- Ahmadi S, "Pruritic urticarial papules and plaques of pregnancy: current status", Australas J Dermatol, 46, pp.53~58 (2005)
- Lammert F, "Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management", J Hepatol, 33, pp.1012~1021 (2000)
- Reyes H, "The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy", Gastroenterol Clin North Am, 21, pp.905~921 (1992)
- Ropponen A, "Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study", Hepatology, 43, pp.723~728 (2006)
- Reyes H, "Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy", Ann Med, 32, pp.94~106 (2000)
- Reyes H, "Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile", J Hepatol, 32, pp.542~549 (2000)
- Ambros-Rudolph CM, "The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe", Arch Dermatol, 143, pp.757~762 (2007)
- Rioseco AJ, "Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome", Am J Obstet Gynecol, 170, pp.890~895 (1994)
- Brites D, "Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy", J Hepatol, 28, pp.91~98 (1998)
- Carter J, "Serum bile acids in normal pregnancy", Br J Obstet Gynaecol, 98, pp.540~543 (1991)
- Glantz A, "Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates", Hepatology, 40, pp.467~474 (2004)
- Zapata R, "Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience", Liver Int, 25, pp.548~554 (2005)
- Williamson C, "Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group", BJOG, 111, pp.676~681 (2004)
- Palma J, "Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo", J Hepatol, 27, pp.1022~1028 (1997)
- Kondrackiene J, "Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy", Gastroenterology, 129, pp.894~901 (2005)
- Sadler LC, "Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy", Br J Obstet Gynaecol, 102, pp.169~170 (1995)
- Roncaglia N, "Obstetric cholestasis: outcome with active management", Eur J Obstet Gynecol Reprod Biol, 100, pp.167~170 (2002)
- García-González E, "Immunology of the cutaneous disorders of pregnancy", Int J Dermatol, 38, pp.721~729 (1999)
- Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Derm Venereol Suppl (Stockh), 92, pp.44~47 (1980)
- Chi CC, "Systematic review of the safety of topical corticosteroids in pregnancy", J Am Acad Dermatol, 62, pp.694~705 (2010)
